The product can not be sold in a country where it is illegal.

Purchase MDAI

Product Name: MDAI
IUPAC Name: 6,7-Dihydro-5H-cyclopenta[f] [1,3]benzodioxol-6-amine
Other Names: 5,6-methylenedioxy-2-aminoindane
Cas Number: 132741-81-2
Molecular Formula: C10H11NO2
Molar Mass: 177.1998 g/mol
Effect: stimulant, psychedelic
Purity of the substance: 99.9%
Physical properties: Crystals, Powder
In Stock
- FREE 7 days from China
- INSURANCE option is local shipping from distributor in your country. FREE & 3 Day Shipping
Payments: WU, MG, Bank Transfer , Pay with Bitcoin - get 10% OFF
Get FREE five samples 2 grams each for the main order.
  • MDAI

Discount program, second order - 5%OFF, third order - 7% OFF

With us securely! - re-shipmentguarantees.

We always offer new legal products of impeccable quality.

Please make sure that the product is legal in your country and not undercontrol before ordering.

We do not sell pharmaceutical products or controlledproducts.

Where to buy MDAI for sale

MDAI (5,6-methylenedioxy-2-aminoindane) is a novel, non-neurotoxic and highly selective serotonin-releasing agent (SSRA) in vitro with the potential for use as an antidepressant. MDAI was developed at the National Institute of Mental Health by a team from Purdue University under the supervision of David E. Nichols.

MDAI is a synthetic indoleamine that acts as a selective serotonin-releasing agent (SSRA) in vitro and produces psychedelic effects in humans. MDAI is known to produce entactogenic effects in human volunteers.

MDAI is a synthetic substance chemically related to other psychedelic drugs like LSD and psilocybin.

MDMA is a synthetic drug that acts as an empathogen, producing feelings of empathy and emotional closeness to others. It also produces entactogenic effects.

MDMA (3,4-methylenedioxymethamphetamine) is the salt form of a synthetic compound. X}

MDAI (5,6-methylenedioxy-2-aminoindane) is a highly potent and selective serotonin reuptake inhibitor (SSRI) that acts as a non-neurotoxic and highly selective serotonin-releasing agent (SSRA) in vitro. Results of animal studies indicate that MDAI may be effective in treating anxiety disorders as well as depression and obsessive-compulsive disorder.

MDAI (5,6-methylenedioxy-2-aminoindane) is a novel, selective serotonin reuptake inhibitor (SSRI) and selective serotonin releasing agent (SSRA), which acts as a non-neurotoxic and highly selective serotonin uptake inhibitor (SSRI) at low doses. Results of animal studies have indicated that MDAI may be a potentially effective pharmacological agent in the treatment of anxiety disorders as well as depression, obsessive-compulsive disorder, sleep disorders, and weight control. This compound has demonstrated superior efficacy to traditional SSRIs such as fluoxetine and sertraline in animal studies, indicating that it may possess fewer side effects than existing antidepressants.

MDAI (5,6-methylenedioxy-2-aminoindane) is a powerful, fast-acting drug with potent anti-depressant and anti-anxiety qualities. It might be useful in treating depression, OCD, PTSD and other psychiatric disorders.

A serotonin reuptake inhibitor (commonly known as an SSRI) is a drug that increases extracellular levels of the neurotransmitter serotonin by inhibiting its reuptake into the presynaptic cell. Contrary to popular belief, the "S" in SSRI does not stand for "serotonin" but for "selective."

The compound acts as a serotonin reuptake inhibitor, and it is highly potent.

MDAI 5,6-methylenedioxy-2-aminoindane is a high-affinity serotonin-releasing agent (HASRA) in vitro but produces opposite effects in vivo. MDAI is a selective serotonin reuptake inhibitor with moderate affinity for the serotonin transporter (SERT).

MDAI (5,6-methylenedioxy-2-aminoindane) is a drug developed in the 1990s by a team led by David E. Nichols at Purdue University. It acts as a non-neurotoxic and highly selective serotonin-releasing agent (SSRA) in vitro and produces entactogen effects in humans at low doses but does not have a dopamine release effect like most other hallucinogens.

MDAI is an entactogen that produces serotonin-mediated entactogenesis effects. MDAI has been used as a substitute for MDMA to avoid the neurotoxicity and dangers associated with MDMA abuse.

1kg $1590

100g $600

1kg $1590

100g $390

1kg $1890

1kg $1690

1kg $1890

200g $590

100g $390

1kg $1590

500g $1199